Indexed logomarkindexed.vc

Sosei

IPO
Biotech
Healthcare
Headquarters
Tokyo
Employees
201–500
Business Model
B2B
Website
sosei.com

About

Sosei Group Corporation (now rebranded as Nxera Pharma) is a Tokyo-based international biopharmaceutical company with expertise in drug discovery and development. The company is known for its GPCR structure-based drug design platform through its Heptares subsidiary.

Summary

Sosei is a Biotech company based in Tokyo, Japan.

Funding History

IPOJul 2004

Acquisitions

Jitsubo

2021

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth Equity·$5.1B·Aug 2022
IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022
inVentiv HealthAcquired

inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate Round·$2.8B·Jan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sosei on Indexed.vc
<a href="https://indexed.vc/companies/sosei"><img src="https://indexed.vc/api/badge/company/sosei" alt="Sosei on Indexed.vc" width="260" height="76" /></a>